Detalhe da pesquisa
1.
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes.
Cell
; 186(6): 1127-1143.e18, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36931243
2.
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Immunity
; 49(6): 1148-1161.e7, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552023
3.
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Immunity
; 55(9): 1749, 2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103861
4.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Cancer
; 130(10): 1784-1796, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261444
5.
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.
Cancer
; 129(1): 71-81, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309837
6.
A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer.
Clin Otolaryngol
; 48(5): 756-765, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212448
7.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Lancet Oncol
; 22(12): 1692-1704, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774225
8.
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Ann Surg Oncol
; 27(11): 4122-4130, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488521
9.
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy.
Br J Cancer
; 116(9): 1141-1147, 2017 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28324889
10.
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
Cancer
; 122(21): 3344-3353, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533448
11.
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Cancer
; 122(21): 3354-3362, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27533633
12.
Carboplatin and paclitaxel after anti-PD-1 or anti-PD-L1 antibody therapy in recurrent and/or metastatic squamous cell carcinoma of head and neck.
Head Neck
; 46(2): 321-327, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997549
13.
The neutrophil-to-lymphocyte ratio in salivary gland cancers treated with pembrolizumab.
Head Neck
; 46(1): 129-137, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897202
14.
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma.
J Clin Oncol
; : JCO2301708, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630954
15.
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial.
Clin Cancer Res
; 28(6): 1157-1166, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965944
16.
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity.
Mol Cancer Res
; 20(6): 983-995, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302641
17.
Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.
Cancer Cell
; 39(10): 1375-1387.e6, 2021 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416167
18.
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
Neuro Oncol
; 23(11): 1961-1973, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880555
19.
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses.
Cancer Immunol Res
; 8(2): 246-254, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31852717
20.
Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
Laryngoscope
; 130(2): E48-E56, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919470